Literature DB >> 17047959

Coexistence of systemic sclerosis with other autoimmune diseases.

Paola Caramaschi1, Domenico Biasi, Alessandro Volpe, Antonio Carletto, Melissa Cecchetto, Lisa Maria Bambara.   

Abstract

To evaluate the coexistence of additional autoimmune disease in a population of patients suffering from systemic sclerosis. The record-charts of 118 Italian patients affected by systemic sclerosis (12 men, 106 women, mean age of 57.2 years, mean duration of disease 8.7 years) followed by a single centre were reviewed; any other diagnose of autoimmune disease the patient was given was recorded. Thirty-eight scleroderma patients (32.2%) were affected by one or two concomitant autoimmune diseases, for a total of 42 diagnoses. The most represented associated autoimmune diseases were autoimmune thyroiditis (17 cases) and primary Sjögren's syndrome (10 cases). Both pulmonary fibrosis as diagnosed by chest X-ray and the extension of skin involvement evaluated by Rodnan total skin score were not correlated with an increased incidence of an additional autoimmune disorder. Our study shows that approximately one third of patients affected by systemic sclerosis developed one or more additional autoimmune diseases. Therefore patients with systemic sclerosis should be carefully evaluated both at onset and during the follow-up for the possible coexistence of other autoimmune disorders.

Entities:  

Mesh:

Year:  2006        PMID: 17047959     DOI: 10.1007/s00296-006-0207-3

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  16 in total

Review 1.  Polymyositis and dermatomyositis (first of two parts).

Authors:  A Bohan; J B Peter
Journal:  N Engl J Med       Date:  1975-02-13       Impact factor: 91.245

Review 2.  Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group.

Authors:  C Vitali; S Bombardieri; R Jonsson; H M Moutsopoulos; E L Alexander; S E Carsons; T E Daniels; P C Fox; R I Fox; S S Kassan; S R Pillemer; N Talal; M H Weisman
Journal:  Ann Rheum Dis       Date:  2002-06       Impact factor: 19.103

Review 3.  Assessment of skin, joint, tendon and muscle involvement.

Authors:  A Akesson; G Fiori; T Krieg; F H van den Hoogen; J R Seibold
Journal:  Clin Exp Rheumatol       Date:  2003       Impact factor: 4.473

4.  Scleroderma (systemic sclerosis): classification, subsets and pathogenesis.

Authors:  E C LeRoy; C Black; R Fleischmajer; S Jablonska; T Krieg; T A Medsger; N Rowell; F Wollheim
Journal:  J Rheumatol       Date:  1988-02       Impact factor: 4.666

5.  Clinical features of patients with systemic sclerosis accompanied by rheumatoid arthritis.

Authors:  M Jinnin; H Ihn; K Yamane; Y Asano; N Yazawa; K Tamaki
Journal:  Clin Exp Rheumatol       Date:  2003 Jan-Feb       Impact factor: 4.473

6.  X chromosome monosomy: a common mechanism for autoimmune diseases.

Authors:  Pietro Invernizzi; Monica Miozzo; Carlo Selmi; Luca Persani; Pier Maria Battezzati; Massimo Zuin; Simona Lucchi; Pier Luigi Meroni; Bianca Marasini; Silvana Zeni; Mitchell Watnik; Francesca R Grati; Giuseppe Simoni; M Eric Gershwin; Mauro Podda
Journal:  J Immunol       Date:  2005-07-01       Impact factor: 5.422

7.  Overlap syndromes in the context of shared autoimmunity.

Authors:  Tatiana Sofía Rodríguez-Reyna; Donato Alarcón-Segovia
Journal:  Autoimmunity       Date:  2005-05       Impact factor: 2.815

8.  Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee.

Authors: 
Journal:  Arthritis Rheum       Date:  1980-05

Review 9.  Autoimmunity in scleroderma: the origin, pathogenetic role, and clinical significance of autoantibodies.

Authors:  Michelle L Harris; Antony Rosen
Journal:  Curr Opin Rheumatol       Date:  2003-11       Impact factor: 5.006

Review 10.  Possible roles and determinants of microchimerism in autoimmune and other disorders.

Authors:  Kakali Sarkar; Frederick W Miller
Journal:  Autoimmun Rev       Date:  2004-08       Impact factor: 9.754

View more
  9 in total

Review 1.  Unraveling the genetic component of systemic sclerosis.

Authors:  José Ezequiel Martín; Lara Bossini-Castillo; Javier Martín
Journal:  Hum Genet       Date:  2012-01-05       Impact factor: 4.132

2.  Clinical and laboratory features of overlap syndromes of idiopathic inflammatory myopathies associated with systemic lupus erythematosus, systemic sclerosis, or rheumatoid arthritis.

Authors:  Lisbeth Aranbicia Aguila; Michelle Remião Ugolini Lopes; Flavia Zon Pretti; Percival Degrava Sampaio-Barros; Fernando Henrique Carlos de Souza; Eduardo Ferreira Borba; Samuel Katsuyuki Shinjo
Journal:  Clin Rheumatol       Date:  2014-07-04       Impact factor: 2.980

3.  The co-occurrence of Hashimoto thyroiditis in primary Sjogren's syndrome defines a subset of patients with milder clinical phenotype.

Authors:  Paola Caramaschi; Domenico Biasi; Cristian Caimmi; Cinzia Scambi; Sara Pieropan; Giovanni Barausse; Silvano Adami
Journal:  Rheumatol Int       Date:  2012-11-05       Impact factor: 2.631

4.  Juvenile diffuse systemic sclerosis/systemic lupus erythematosus overlap syndrome--a case report.

Authors:  Heng-Kuei Lin; Jiaan-Der Wang; Lin-Shien Fu
Journal:  Rheumatol Int       Date:  2011-05-01       Impact factor: 2.631

5.  Celiac disease in a rheumatology unit: a case study.

Authors:  Paola Caramaschi; Annamaria Stanzial; Alessandro Volpe; Sara Pieropan; Lisa Maria Bambara; Antonio Carletto; Domenico Biasi
Journal:  Rheumatol Int       Date:  2007-11-24       Impact factor: 2.631

6.  High burden of skin sclerosis is associated with severe organ involvement in patients with systemic sclerosis and systemic sclerosis overlap syndrome.

Authors:  Thapat Wannarong; Chayawee Muangchan
Journal:  Rheumatol Int       Date:  2018-09-11       Impact factor: 2.631

7.  Disease progression in systemic sclerosis-overlap syndrome is significantly different from limited and diffuse cutaneous systemic sclerosis.

Authors:  Pia Moinzadeh; Elisabeth Aberer; Keihan Ahmadi-Simab; Norbert Blank; Joerg H W Distler; Gerhard Fierlbeck; Ekkehard Genth; Claudia Guenther; Ruediger Hein; Joerg Henes; Lena Herich; Ilka Herrgott; Ina Koetter; Alexander Kreuter; Thomas Krieg; Kathrin Kuhr; Hanns-Martin Lorenz; Florian Meier; Inga Melchers; Hartwig Mensing; Ulf Mueller-Ladner; Christiane Pfeiffer; Gabriela Riemekasten; Miklós Sárdy; Marc Schmalzing; Cord Sunderkoetter; Laura Susok; Ingo H Tarner; Peter Vaith; Margitta Worm; Gottfried Wozel; Gabriele Zeidler; Nicolas Hunzelmann
Journal:  Ann Rheum Dis       Date:  2014-01-03       Impact factor: 19.103

8.  Overlap Syndrome-Systemic Sclerosis, Systemic Lupus Erythematosus and Dermatomyositis - Case Report.

Authors:  C Cirstea; A L Barbulescu; L E Stoica; F A Vreju; P L Ciurea
Journal:  Curr Health Sci J       Date:  2015-03-15

9.  Overlap syndromes in systemic sclerosis.

Authors:  Ewa Wielosz; Maria Majdan; Magdalena Dryglewska; Bożena Targońska-Stępniak
Journal:  Postepy Dermatol Alergol       Date:  2018-06-18       Impact factor: 1.837

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.